Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma.
Katamura Y, Aikata H, Hashimoto Y, Kimura Y, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Kawakami Y, Takahashi S, Kenjo M, Chayama K.
Katamura Y, et al. Among authors: kenjo m.
Hepatol Res. 2010 Dec;40(12):1195-203. doi: 10.1111/j.1872-034X.2010.00729.x. Epub 2010 Oct 7.
Hepatol Res. 2010.
PMID: 21040275